Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
Deisseroth AB et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
Immunological purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
Gribben JG et al. Immunological purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 325: 1525-1533.
Structure of the gene encoding CD34, a human hematopoietic stem cell antigen
Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 1992; 12: 788-794.
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first choice phase: Correlations with acute graft-versus-host disease and relapse
Cross NC et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first choice phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 1993; 84: 67-74.
Immunoglobulin gene 'fingerprinting': An approach to analysis of B lymphoid clonality in lymphoproliferative disorders
Deane M, Norton JD. Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol 1991; 77: 274-281.